Allergy medication affects erection in ways that are not always clearly explained on the packet, yet this is a concern raised by many men in the UK. Millions of people rely on antihistamines, decongestants, and nasal corticosteroids to manage hay fever, allergic rhinitis, and urticaria — but some of these treatments have pharmacological properties that may interfere with erectile function. First-generation antihistamines carry anticholinergic effects that can disrupt the nerve signals needed for erection, while decongestants may reduce penile blood flow through vasoconstriction. This article explains which allergy treatments carry the greatest risk, when to seek medical advice, and how switching medications may help.

How Allergy Medications Can Affect Sexual Function

Some allergy medications — particularly first-generation antihistamines and decongestants — may impair erections through anticholinergic interference with parasympathetic nerve signals and vasoconstriction that limits penile blood flow.

Allergy medications are among the most commonly used drugs in the UK, with millions of people relying on antihistamines, nasal corticosteroids, and decongestants to manage conditions such as hay fever, allergic rhinitis, and urticaria. While these treatments are generally well tolerated, some allergy medications have pharmacological properties that may, in theory, influence sexual function in men, including the ability to achieve or maintain an erection.

The proposed mechanisms are largely based on known pharmacological actions rather than large-scale clinical trial evidence. Some antihistamines — particularly older, first-generation types — have anticholinergic and sedative properties that may dampen the nervous system signals required for sexual arousal and erection. The parasympathetic nervous system plays a central role in initiating an erection, and drugs that interfere with acetylcholine activity could, in some individuals, impair this process (as described in BNF monographs for chlorphenamine and promethazine). Additionally, some decongestants act as vasoconstrictors, which may theoretically reduce blood flow to the penis — a key physiological requirement for erectile function.

It is also worth noting that allergy symptoms themselves — such as chronic nasal congestion, poor sleep, and fatigue — can independently reduce libido and sexual performance. This makes it important to distinguish between the effects of the condition and the effects of the medication. A careful, honest conversation with a GP or pharmacist is often the best starting point for understanding what may be contributing to any changes in sexual function.

Which Antihistamines and Treatments Are Most Likely to Cause Issues

First-generation antihistamines (e.g. chlorphenamine) and oral decongestants carry the greatest risk; second-generation antihistamines and nasal corticosteroids are far less likely to affect erectile function.

Not all allergy medications carry the same risk of affecting erectile function. Understanding the differences between drug classes can help men make more informed choices about their treatment.

First-generation antihistamines — such as chlorphenamine (Piriton) and promethazine — have significant anticholinergic and sedative properties. Because they cross the blood-brain barrier readily, they are more likely than newer agents to cause CNS and anticholinergic effects that could affect sexual function in some people, including interference with the nerve signals needed for erection and ejaculation. Sedation may also reduce sexual desire and performance. These effects are documented in the BNF and individual Summary of Product Characteristics (SmPCs) for these medicines.

Second-generation antihistamines — including cetirizine, loratadine, and fexofenadine — are far less sedating and have a much lower anticholinergic burden. As a result, they are considerably less likely to affect erectile function. NICE Clinical Knowledge Summaries (CKS) for allergic rhinitis and urticaria recommend non-sedating second-generation antihistamines as first-line treatment, precisely because of their more favourable side-effect profile.

Decongestants such as pseudoephedrine and xylometazoline act as sympathomimetic agents, causing vasoconstriction. While effective at relieving nasal congestion, their vasoconstrictive properties may theoretically reduce penile blood flow, particularly with prolonged use. Oral decongestants carry a greater systemic risk than topical nasal sprays. Men with cardiovascular disease or hypertension should exercise particular caution with oral decongestants, and topical nasal decongestants should not be used for more than seven consecutive days (BNF; SmPCs for pseudoephedrine and xylometazoline).

Nasal corticosteroids (e.g., fluticasone, mometasone) are generally considered safe with respect to sexual function when used at recommended doses, as systemic absorption is minimal. Their SmPCs and BNF entries do not list erectile dysfunction as a recognised adverse effect, making them a preferred option for long-term allergic rhinitis management.

Understanding Erectile Dysfunction as a Medication Side Effect

Drug-induced erectile dysfunction can occur via reduced blood flow, anticholinergic nerve interference, hormonal disruption, or sedation; in allergy medications, anticholinergic effects and vasoconstriction are the most plausible mechanisms.

Erectile dysfunction (ED) is defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity, typically when symptoms have been present for approximately three months or more. It is a common condition in the UK, though precise prevalence estimates vary across studies; data from the Natsal-3 survey and BSSM guidance confirm it affects a substantial proportion of men, with prevalence increasing with age. While lifestyle factors, cardiovascular disease, diabetes, and psychological causes are the most frequently cited contributors, medication-induced ED is a well-recognised but often overlooked cause (NICE CKS: Erectile dysfunction; NHS: Erectile dysfunction).

Drug-induced ED can occur through several mechanisms:

• Reduced blood flow — vasoconstrictive drugs limit the arterial dilation needed for erection

• Hormonal disruption — some medications affect testosterone or prolactin levels

• Neurological interference — anticholinergic drugs impair the parasympathetic signals that trigger erection

• Sedation and reduced libido — CNS depressants lower sexual desire and arousal

In the context of allergy medication, the most plausible mechanisms are anticholinergic interference (with first-generation antihistamines) and vasoconstriction (with decongestants). It is important to note that the evidence specifically linking allergy medications to ED is largely based on pharmacological reasoning and case reports rather than large-scale clinical trials. However, individual responses to medication vary, and any new or worsening sexual difficulty following the start of a new treatment warrants attention and discussion with a healthcare professional.

Men should also be aware that psychological factors, such as anxiety about sexual performance, can compound medication-related effects, creating a cycle that may be difficult to break without addressing both the physical and emotional dimensions.

When to Speak to a GP or Pharmacist About Your Symptoms

Men should speak to a GP or pharmacist if erectile difficulties begin shortly after starting an allergy medication, persist for more than a few weeks, or are accompanied by red-flag features such as reduced libido or signs of hypogonadism.

Many men feel reluctant to discuss sexual health concerns with a healthcare professional, but erectile difficulties linked to medication are a legitimate medical issue and should be raised without embarrassment. Early discussion can lead to simple, effective solutions.

You should speak to a GP or pharmacist if:

• You notice a change in erectile function shortly after starting a new allergy medication

• Erectile difficulties persist for more than a few weeks

• You are using first-generation antihistamines or oral decongestants regularly

• You have other risk factors for ED, such as cardiovascular disease, diabetes, or low mood

• Your allergy symptoms are poorly controlled and you are unsure which treatment is most appropriate

Seek prompt medical advice if you notice any of the following red-flag features:

• ED accompanied by reduced libido, fatigue, or other signs that may suggest low testosterone (hypogonadism)

• Penile deformity or painful erections, which may indicate Peyronie's disease

• Neurological symptoms alongside ED

• ED following pelvic trauma or surgery

• Symptoms that may suggest underlying cardiovascular disease

A pharmacist is an excellent first point of contact, particularly for over-the-counter allergy treatments. They can review your current medications, identify potential interactions or side effects, and recommend alternatives without the need for a GP appointment.

If the issue appears more complex — for example, if ED persists after switching medications — a GP assessment is appropriate. GPs may investigate using blood tests including morning total testosterone (which should be repeated if low, with consideration of LH and prolactin if hypogonadism is suspected), fasting glucose, lipid levels, and blood pressure measurement, alongside a full medication review (NICE CKS: Erectile dysfunction). Depending on findings, referral may be made to urology for structural or complex ED, endocrinology for hormonal abnormalities, or psychosexual therapy for psychogenic factors.

Always inform your GP or pharmacist of all medications you are taking, including over-the-counter products, as these are frequently overlooked in consultations. If you believe an allergy medication has caused a side effect, you can report this directly to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk).

Switching or Adjusting Allergy Treatment to Reduce Side Effects

Switching from a first-generation to a second-generation antihistamine, or replacing oral decongestants with intranasal corticosteroids, can significantly reduce the risk of medication-related erectile difficulties without compromising allergy control.

If there is a reasonable suspicion that an allergy medication is contributing to erectile difficulties, the first step is usually to review whether the current treatment is the most appropriate option. In many cases, switching to a different drug class or formulation can resolve the issue without compromising allergy control.

Practical steps that may help include:

• Switching from a first-generation to a second-generation antihistamine — replacing chlorphenamine with loratadine or fexofenadine significantly reduces anticholinergic and sedative effects (NICE CKS: Rhinitis — allergic and non-allergic)

• Replacing oral decongestants with intranasal corticosteroids — nasal sprays such as fluticasone or budesonide are highly effective for allergic rhinitis and have minimal systemic effects; note that they require regular daily use for maximal benefit and may take several days to reach full effect

• Using topical nasal decongestants short-term only — xylometazoline nasal spray should not be used for more than seven consecutive days to avoid rebound congestion and systemic vasoconstrictive effects (BNF; SmPC for xylometazoline)

• Timing of doses — taking sedating antihistamines at night rather than during the day may reduce their impact on daytime sexual function, though this does not eliminate the anticholinergic effect, and residual next-day drowsiness and anticholinergic burden should be borne in mind

It is important not to stop prescribed medication abruptly without speaking to a GP or pharmacist first, particularly if the allergy condition is severe or if the medication is managing multiple symptoms.

In some cases, allergen immunotherapy (desensitisation) may be considered for suitable patients with persistent allergic rhinitis, potentially reducing the long-term need for daily antihistamine use. NICE Technology Appraisal TA201 supports the use of sublingual grass pollen allergen extract (GRAZAX) for grass pollen-induced allergic rhinitis in adults; other sublingual immunotherapy products may have separate NICE appraisals, and a specialist referral is required to assess suitability.

NHS and NICE Guidance on Managing Allergy Treatment and Men's Health

NICE CKS recommends second-generation antihistamines and intranasal corticosteroids as first-line allergy treatments; NHS guidance on erectile dysfunction highlights medication review as a key part of assessment.

The NHS and NICE provide clear guidance on the management of allergic conditions, with an emphasis on using the most effective treatment at the lowest necessary dose. For allergic rhinitis — the most common allergy condition in the UK — NICE CKS recommends second-generation antihistamines and intranasal corticosteroids as first-line treatments, because they offer good efficacy with a more favourable side-effect profile compared to older agents (NICE CKS: Rhinitis — allergic and non-allergic; NHS: Hay fever).

With regard to erectile dysfunction, the NHS recognises it as a common and treatable condition and encourages men to seek help rather than suffer in silence. Medication review is highlighted as an important part of the assessment process (NHS: Erectile dysfunction; NICE CKS: Erectile dysfunction). The MHRA requires that all licensed medications include information about known sexual side effects in their patient information leaflets, so men are encouraged to read these carefully when starting any new treatment.

For men managing both allergy conditions and erectile dysfunction, an integrated approach is recommended:

• Review all medications with a GP or pharmacist, including over-the-counter products

• Optimise allergy treatment using evidence-based, low-risk options as outlined in NICE CKS and NHS guidance

• Address lifestyle factors that contribute to both allergy severity and ED, such as smoking, alcohol use, and obesity

• Seek psychological support if anxiety or low mood is contributing to sexual difficulties (psychosexual therapy is available via NHS referral)

• Report suspected side effects to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk)

Men should feel empowered to raise concerns about how their medications affect their quality of life — including their sexual health — as part of routine healthcare conversations. Specialist support, including urology, endocrinology, and psychosexual services, is available through NHS referral pathways where needed (BSSM guideline on erectile dysfunction; BAUS patient information on erectile dysfunction).

Frequently Asked Questions